← Back

Infrastructure for Decentralized Patient-Reported Clinical Studies

Decentralized patient reporting for clinical studies would amplify and diversify patient participation at decreased cost by reducing logistical and geographic barriers. It could compound and incorporate subjective patient experiences at large scale and would improve public accessibility of trial data.

R&D Gaps (2)

Clinical trial designs are often inefficient, resulting in high costs, lengthy timelines, and suboptimal patient outcomes. Innovative trial designs and decision-support tools are required to streamline the clinical evaluation process and accelerate therapeutic development.
Current clinical trial designs are not sufficiently optimized for gathering robust evidence, leading to inefficiencies and suboptimal outcomes.